プログラム委員会
-
Toshiyoshi Tominaga, PhD Life Science Department, Advisor
SunFlare Co., Ltd, Japan -
Koichi Miyazaki, PhD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan -
Ari Fujishiro Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Division
Daiichi Sankyo Co., Ltd., Japan -
Tomohisa Hayakawa, PhD Corporate Officer; Head of BD & PM
EPS International Holdings Co., Ltd., Japan -
Shun Jin, MBA Head – BD & RA
PharmaGend Global Medical Services Pte Ltd, Singapore -
Akihito Kakiuchi, MSc, RPh Respiratory TA Office, Medicines Development, Japan Development &Medical Affairs
GlaxoSmithKline K.K., Japan -
Yoshiko Komuro, PhD Director, Office of Research Administration
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Jessica (Chih Min) Lin, MBA, MSc General Manager of Development Division
Chugai Pharma Taiwan Ltd., Taiwan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan -
Kosuke Mitsui, MBA, MSc, PMP President & General Manager
Chugai Pharma Science (Beijing) Co., Ltd., China -
Shiho Noda, DVM Japan/Asia Clinical Development 1, Astellas Pharma Global Development
Astellas Pharma Inc., Japan -
Minsoo Park
KCGI, Korea, Republic of -
Kihito Takahashi Head of R&D/Medical Affairs Hub Japan
Swedish Orphan Biovitrium (SOBI) Japan, Japan -
Tetsuomi Takano, RPh Editor-in-Chief
Drug R&D Expert, Japan -
Xue TANG Drug Safety Unit Regional Head (DRH),
APAC Pfizer, China -
Yoshiaki Uyama, PhD, MS, RPh Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
